- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00364104
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children (HEIDC)
Randomized Field Intervention Trial of H. Pylori Eradication to Reduce Iron Deficiency Among Children in El Paso, Texas
Study Overview
Status
Conditions
Detailed Description
For the last 12 years, scientific evidence has mounted linking Helicobacter pylori infection with iron deficiency and iron deficiency anemia. Reports from around the world on several cases of iron deficiency anemia refractory to iron supplementation among children infected with Helicobacter pylori, most without evident ulcers, clearly indicate that such cases have been cured of their anemia after receiving a course of Helicobacter pylori eradication therapy. Several studies based on national surveys, including one on the U.S. National Health and Nutrition Examination Survey data and conducted by the authors of this proposal, have found an association between Helicobacter pylori infection and the levels of iron stores. However, these studies fail to demonstrate that anemia follows Helicobacter pylori infection. Moreover, most previous research has been conducted outside of the contiguous U.S. and has not included young children, one of the high-risk populations for iron deficiency and iron deficiency anemia. Data on this age-group is most needed to develop sound public health interventions.
We propose to conduct such a study among children living in El Paso, Texas, a city located on the U.S.-Mexico border. A series of studies have been conducted in that city by the authors of this proposal, including a National Institutes of Health sponsored study aiming to describe the natural history of Helicobacter pylori infection in children from birth to age seven years (84 months). We hypothesize that the Helicobacter pylori bacterium decreases iron from the stomach and that this effect of the infection can be identified among persons with iron deficiency as well as among persons with normal iron stores. Currently, the clinical management of the most extreme form of iron deficiency, that is iron deficiency anemia, relies only on supplemental iron therapy. For ethical reasons, our study will identify children with anemia from the study, and will assign them to one of the arms receiving iron supplementation. Our study will determine whether a combination of iron supplementation and sequential Helicobacter pylori eradication therapy yields higher increases of iron stores than each of these treatments alone. To summarize, our main hypothesis is that Helicobacter pylori infection is associated with iron deficiency such that Helicobacter pylori eradication would result in an increase in the levels of:
- serum ferritin,
- transferrin saturation, and
- hemoglobin.
To test these hypotheses we will randomly assign 125 Helicobacter pylori-infected children (3 to 10 years of age) into each of the following four groups: Helicobacter pylori eradication treatment, iron supplementation, Helicobacter pylori eradication plus iron supplementation, or placebo. We plan to recruit infected children through a household survey in El Paso, screen their Helicobacter pylori infection status by a stool test, and invite their parents to undergo a confirmatory breath test. Infected children randomly allocated to those four arms of the study will be followed closely during the 6 weeks they are taking the study medication to record any adverse event, followed by a visit at 45 days after treatment to tell whether or not those receiving the medication had their infection eradicated, between 6 and 12 months for hematological evaluation to compare with the baseline levels of iron stores.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Texas
-
El Paso, Texas, United States, 79905
- Texas Tech University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children 3-10 years of age
- Helicobacter pylori infected, asymptomatic
- Healthy otherwise
- Parents provided consent/assenting children 7-10 years of age
Exclusion Criteria:
- Parental consent or child assent not obtained
- History of antibiotic-related allergic episodes
- Children with a history of allergy, asthma, hay fever or urticaria
- Phenylketonurics
- Abnormal renal and hepatic functions as evaluated through albumin, bilirubin, AST (or SGOT), ALT (or SGPT), alkaline phosphatase and GGT-P
- History of peptic ulcer
- History of recent (< 1 month) severe disease
- History of recent (< 1 month) use of antibiotics, antacids, H2 receptor antagonists, proton pump inhibitors and remedies containing bismuth
- Parents uncertain about staying in El Paso for the next year
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: D
|
Placebo only (10-days of matching placebo of Hp eradication therapy and 6-weeks of matching iron supplementation).
|
Experimental: A
A 10-day course of Hp infection sequential eradication therapy plus 6-weeks of iron supplementation
|
A 10-day course of Hp infection sequential eradication therapy plus 6-weeks of iron supplementation
|
Experimental: B
The 10-day course of Hp infection sequential eradication therapy only plus 6-weeks of matching placebo of iron supplementation
|
A 10-day course of Hp infection sequential eradication therapy only plus 6-weeks of matching placebo of iron supplementation
|
Experimental: C
6-weeks of iron supplementation only plus 10-days of matching placebo of Hp infection eradication therapy
|
6-weeks of iron supplementation only plus 10-days matching placebo of Hp infection eradication therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percent change of serum ferritin
Time Frame: between 6 and 12 months
|
between 6 and 12 months
|
Percent change of transferrin saturation
Time Frame: between 6 and 12 months
|
between 6 and 12 months
|
Percent change of hemoglobin
Time Frame: between 6 and 12 months
|
between 6 and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Proportion of children who cleared their H. pylori infection
Time Frame: 45+ days after completing treatment
|
45+ days after completing treatment
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Victor M Cardenas, MD, MPH, PhD, University of Texas-Houston School of Public Health El Paso Regional Campus
Publications and helpful links
General Publications
- Cardenas VM, Prieto-Jimenez CA, Mulla ZD, Rivera JO, Dominguez DC, Graham DY, Ortiz M. Helicobacter pylori eradication and change in markers of iron stores among non-iron-deficient children in El Paso, Texas: an etiologic intervention study. J Pediatr Gastroenterol Nutr. 2011 Mar;52(3):326-32. doi: 10.1097/MPG.0b013e3182054123.
- Prieto-Jimenez CA, Cardenas VM, Fischbach LA, Mulla ZD, Rivera JO, Dominguez DC, Graham DY, Ortiz M. Double-blind randomized trial of quadruple sequential Helicobacter pylori eradication therapy in asymptomatic infected children in El Paso, Texas. J Pediatr Gastroenterol Nutr. 2011 Mar;52(3):319-25. doi: 10.1097/MPG.0b013e318206870e.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-SPH-06-0374
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron Deficiency
-
Pennington Biomedical Research CenterRecruitingIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia TreatmentUnited States
-
King's CollegeCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
Children's Hospital Los AngelesNot yet recruitingAnemia | Iron Deficiency Anemia | Anemia, Iron Deficiency | IDA - Iron Deficiency AnemiaUnited States
-
Swiss Federal Institute of TechnologyUnited States Agency for International Development (USAID); Quadram Institute... and other collaboratorsCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)Peru
-
Arrowhead Regional Medical CenterRecruitingIron Deficiency Anemia of PregnancyUnited States
-
Société des Produits Nestlé (SPN)CompletedIron-deficiency | Anemia | Iron Deficiency AnemiaPhilippines
-
Swiss Federal Institute of TechnologyUniversity of MalawiCompletedIron-deficiency | Iron Deficiency AnemiaMalawi, Switzerland
-
Johann Wolfgang Goethe University HospitalLudwig-Maximilians - University of MunichCompletedNon-invasive Diagnostics of Iron Deficiency in Surgical Patients by Measuring Zinc Protoporphyrin-IXIron-deficiency | Anemia | Iron Deficiency AnemiaGermany
-
Kansas State UniversityUnited States Department of Agriculture Foreign Agricultural Service; American...CompletedIron-deficiency | Iron Deficiency AnemiaUnited States
-
Baylor College of MedicineNational Heart, Lung, and Blood Institute (NHLBI)CompletedIron-deficiency | Iron Deficiency AnemiaUnited States
Clinical Trials on Quadruple sequential Helicobacter pylori eradication + iron sulfate
-
Shandong UniversityRecruitingHelicobacter Pylori InfectionChina
-
Shandong UniversityRecruitingHelicobacter Pylori InfectionChina
-
Fudan UniversityRecruitingHelicobacter Pylori Infection | MALT Lymphoma of StomachChina
-
Hangzhou Grand Biologic Pharmaceutical, Inc.The First Affiliated Hospital of Nanchang University; Xi'an Central Hospital; Nanjing First Hospital, Nanjing Medical University and other collaboratorsUnknown
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions and other collaboratorsCompleted
-
National University of MalaysiaCompletedResponse to Levodopa | Motor Outcomes | Quality of Life OutcomesMalaysia
-
Seoul National University Bundang HospitalCompletedGastric CancerKorea, Republic of
-
Ajou University School of MedicineUnknownHelicobacter EradicationKorea, Republic of
-
National Cancer Center, KoreaCompletedGastric CancerKorea, Republic of
-
Ziauddin UniversityCompletedHelicobacter Pylori InfectionPakistan